Cardiology CME

  • 25% OFF W/ CODE: CME25

    Comprehensive Review of Interventional Cardiology

    Key Topics in Interventional Cardiology CME

    Comprehensive Review of Interventional Cardiology Is an in-depth continuing medical education guide to the diagnostic, management, and technical skills required in this continually advancing field.

    Led by Dr. Deepak L. Bhatt, authoritative interventional cardiologists cover topics like anticoagulation, cardiogenic shock, bifurcation stenting, bypass grafts, renal artery stenting, pericardial interventions, and more. This online CME course will help you to:

    • List effective lipid-lowering pharmacologic therapies
    • Illustrate carotid and cerebrovascular interventions
    • Outline interventions used for stable angina and silent ischemia
    • Discuss different peripheral interventions for upper and lower extremities
    • Describe interventions for patent foramen ovale and atrial septal defect closure
    • Distinguish between the various stents used to treat coronary disease

    Learning Objectives

    At the conclusion of this CME activity, the participant will be able to:

    • List the most effective lipid-lowering pharmacologic therapies
    • Describe carotid and cerebrovascular interventions
    • Explain the concerns for the interventional cardiologists about a patient with diabetes
    • Summarize the interventions used for stable angina and silent ischemia
    • Discuss the different peripheral interventions for upper extremities and lower extremities
    • Describe interventions for patent foramen ovale and atrial septal defect closure
    • Differentiate among the various stents used to treat coronary disease
    • Name efficacious clinical guidelines in the practice of interventional cardiology
    • Summarize transcatheter intervention use for congenital heart disease

    Intended Audience

    This educational activity was designed for cardiologists.

    See full details chevron_right
    • Cost: $1095
    • Credit hours: 26.50
    • CME credits awarded by: Oakstone Publishing, LLC.
    • Format: On-Demand Online
    • Material last updated: November 30, 2019
    • Expiration of CME credit: November 30, 2022
  • Vascular Imaging Educators Workshop

    Meetings By Mail presents the ALL NEW Vascular Imaging Educators Workshop (VIEW), featuring twenty hours of exceptional content dedicated to the diagnosis and treatment of vascular disease.  Provided by the Society for Vascular Ultrasound through its 43rd Annual Conference, this activity delivers a complete educational experience for all vascular laboratory professionals.  Worth 20 AMA PRA Category I Credits™VIEW MEETS VASCULAR LAB CME REQUIREMENTS FOR ACCREDITATION.

    See full details chevron_right
    • Cost: $645
    • Credit hours: 20
    • CME credits awarded by: Global Education Group
    • Format: On-Demand Online, DVD-ROM
    • Material last updated: 02/15/2021
    • Expiration of CME credit: 02/14/2024
  • FREE

    Advances in the management of Fabry disease

    Fabry disease is characterized by a deficiency of the glycoside hydrolase enzyme alpha galactosidase A, resulting in the accumulation of the glycolipid globotriaosylceramide throughout the body, particularly prominently in the blood vessels. A defect in the enzyme alpha galactosidase A results in glycosphingolipid accumulation, ultimately leading to multi-organ dysfunction and the patient’s premature death. Early symptoms, which occur during childhood, involve pain and may include Raynaud phenomenon, paresthesias, and arthralgia in the extremities and proximal limbs, as well as impaired gastrointestinal emptying, resulting in abdominal pain, diarrhea, early satiety, postprandial bloating, nausea, and vomiting. In adulthood, the disease’s impact spreads beyond and begins to affect the cardiac and renal systems.

    Target Audience:

    The following healthcare professionals: cardiologists, nephrologists, pediatricians, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists; and any other healthcare professionals with an interest in or who may clinically encounter patients with Fabry disease.

    By the end of the session the participant will be able to:

    • Describe the pathophysiology of Fabry disease diagnosis and treatment.
    • Describe the challenges associated with diagnosis of Fabry disease.
    • List present and emerging treatment options for Fabry disease and apply them to patient cases using evidence-based medicine.
    • Describe the benefits and any applicable risks of therapeutic approaches to Fabry disease and take them into account when formulating a treatment plan for patients.
    See full details chevron_right
    • Cost: Free
    • Credit hours: .75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 08/13/2020
    • Expiration of CME credit: 08/13/2022
  • FREE

    CME: Fabry disease: Updates from recent research findings

    Fabry disease is characterized by a deficiency of the glycoside hydrolase enzyme alpha galactosidase A, resulting in the accumulation of the glycolipid globotriaosylceramide throughout the body, particularly prominently in the blood vessels.

    After completing this course, physicians will better be able to:

    • Describe the pathogenesis, clinical presentations, complications, and epidemiology of Fabry disease including updated material presented at the 15th Annual WORLDSymposium
    • Describe principles and problems regarding screening for and diagnosing Fabry disease that can applied to patient cases
    • Describe emerging therapies for Fabry disease based on research presented at the 15th Annual WORLDSymposium
    • Design and implement appropriate therapeutic plans for treatment of Fabry disease based on research presented at the 15th Annual WORLDSymposium

    Target Audience: cardiologists, nephrologists, pediatricians, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists; and any other healthcare professionals with an interest in or who may clinically encounter patients with Fabry disease.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1.25
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 6/25/19
    • Expiration of CME credit: 6/25/21
  • Cleveland Clinic 22nd Valve Disease, Structural Interventions and Diastology Summit

    Cleveland Clinic’s world renowned faculty congregates with several guest speakers for the 22nd Valve Disease, Structural Interventions and Diastology Summit. This activity will focus on mitral, aortic and tricuspid valve diseases, while providing a unique opportunity for updates in new and emerging topics. These include basic and advanced imaging techniques such as 3-D echocardiography, fusion imaging, strain imaging and interventional echo. Worth up to 16.75 AMA PRA Category I Credits™, this enduring material meets Echo Lab CME requirements for Physicians and sonographers.

    See full details chevron_right
    • Cost: $595
    • Credit hours: 16.75
    • CME credits awarded by: Cleveland Clinic
    • Format: On-Demand Online
    • Material last updated: 5/15/20
    • Expiration of CME credit: 5/14/2
  • FREE

    ScientiaCME Cardiology/Pulmonology

    ScientiaCME Cardiology/Pulmonology has two courses at this time:

    In order to get credit from ScientiaCME, you must first establish a username and password.

    Target Audience: Physicians specializing in Cardiology, Chest Medicine, Family Medicine, Internal Medicine.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 2
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Expiration of CME credit: Two years after release
  • FREE

    Hereditary transthyretin amyloidosis (ATTR) treatment strategies: best practices and emerging therapies

    Transthyretin amyloidosis (ATTR) is a progressive, multisystem, life-threatening disorder characterized by the extracellular deposition of misfolded, insoluble amyloid fibrils.

    After completing Hereditary transthyretin amyloidosis (ATTR) treatment strategies: best practices and emerging therapies physicians will better be able to:

    • Describe the pathophysiology of ATTR such that it might inform treatment mechanisms
    • Describe available therapies used for treatment of ATTR and explain current literature supporting use of those therapies
    • Design and implement an appropriate therapeutic plan for treatment of ATTR
    • Describe future therapies currently being investigated for the treatment of ATTR

    Target Audience: neurologists, cardiologists, and hematologists; physician assistants, nurse practitioners, nurses, and pharmacists in the aforementioned areas of specialty; and any other HCPs with an interest in or who may clinically encounter patients with ATTR.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 0.75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: March 28, 2019
    • Expiration of CME credit: March 28, 2021
  • FREE

    Updates in the pharmacotherapeutic management of familial hypercholesterolemia (FH): present and emerging treatment options

    Familial hypercholesterolemia (FH), also known as type II hyperlipoproteinemia, is an autosomal dominant disorder characterized by elevated plasma LDL-C levels in the absence of hypertriglyceridemia (or if triglycerides are elevated, they are so independently of FH).

    After completing Updates in the pharmacotherapeutic management of familial hypercholesterolemia (FH): present and emerging treatment options physicians will better be able to:

    • Describe the pathophysiology and genetics of FH such that they might inform treatment mechanisms
    • Describe presently available and emerging treatment options for FH and apply them to patient cases
    • Evaluate a FH treatment plan and suggest modifications for improvement
    • Describe clinical and logistical challenges associated with treating and educating patients with FH

     

    Target Audience: Cardiology and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in cardiology; and any other clinicians with an interest in FH.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: October 22, 2018
    • Expiration of CME credit: October 22, 2020
  • FREE

    CME: Treatment strategies in Fabry disease

    Fabry disease is characterized by a deficiency of the glycoside hydrolase enzyme alpha galactosidase A, resulting in the accumulation of the glycolipid globotriaosylceramide throughout the body, particularly prominently in the blood vessels. A defect in the enzyme alpha galactosidase A results in glycosphingolipid accumulation, ultimately leading to multi-organ dysfunction and the patient’s premature death. Early symptoms, which occur during childhood, involve pain and may include Raynaud phenomenon, paresthesias, and arthralgia in the extremities and proximal limbs, as well as impaired gastrointestinal emptying, resulting in abdominal pain, diarrhea, early satiety, postprandial bloating, nausea, and vomiting. In adulthood, the disease’s impact spreads beyond and begins to affect the cardiac and renal systems.

    By the end of the session the participant will be able to:

    • Describe the importance of quick and accurate Fabry disease diagnosis and treatment.
    • Using established methods, determine likelihood of Fabry disease given a patient case.
    • Appropriately describe available therapies used for treatment of Fabry disease and explain current literature supporting use of those therapies.
    • Design and implement an appropriate therapeutic plan for treatment of Fabry disease.
    • Describe future therapies currently being investigated for the treatment of Fabry disease.

    Target Audience: The following healthcare professionals: cardiologists, nephrologists, pediatricians, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists; and any other healthcare professionals with an interest in or who may clinically encounter patients with Fabry disease.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 9/4/19
    • Expiration of CME credit: 9/4/21
  • 25% OFF W/ CODE: CME25
    FEATURED

    Echocardiography – A Comprehensive Review

    Discover New Cardiology Guidelines with Online CME

    Oakstone’s Echocardiography – A Comprehensive Review online CME focuses on contemporary clinical standards, in addition to presenting new available modalities, emerging indications, and new approaches to echocardiography.

    Directed by Scott D. Solomon, MD and Maja Cikes, MD, PhD, this continuing medical education program includes 36 lectures organized in four sections – general principles, disorders, modalities, and settings. It’s available online so you can earn CME credits whenever, wherever, and will help you to:

    • Understand clinical indications and quality assurance issues
    • Recognize clinical uses, advantages, potential complications, and limitations of new available modalities
    • Know the techniques needed to evaluate various diseases and disorders
    • Summarize the characteristic findings of diseases of the myocardium

    Learning Objectives

    Upon completion of this activity, participants will be able to:

    • Discuss image acquisition and Doppler analysis in echocardiography
    • Explain the clinical indications and quality assurance issues of echocardiography
    • Recognize the limitations and potential artifacts of an echocardiogram
    • Describe the techniques needed to evaluate mitral valve disease
    • Summarize the characteristic findings of diseases of the myocardium
    • Explain the advantages of point-of-care handheld echocardiography
    • Appraise the clinical uses and potential complications of stress, exercise, transesophageal, and contrast echocardiography
    • Describe the principles and applications of three-dimensional echocardiography
    • Discuss the role of echocardiography in the intraoperative, critical care, and emergency department settings
    • Summarize the use of echocardiography in cardio-oncology as a tool to provide comprehensive insight into cardiac structure and function
    • Describe the therapeutic and prognostic implications for imaging the atria

    Intended Audience

    This educational activity was designed for cardiologists and others interested in echocardiography.

    See full details chevron_right
    • Cost: $695
    • Credit hours: 30.5
    • CME credits awarded by: Oakstone Publishing, LLC
    • Format: On-Demand Online, Online Video, Online Audio, Audio CD
    • Material last updated: January 31, 2020
    • Expiration of CME credit: January 31, 2023